PUNE, India, May 31, 2016 /PRNewswire/ --
RnRMarketResearch.com adds "Asthma - Pipeline Review, H1 2016" market research report with comparative analysis of Asthma therapy at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Asthma and special features on late-stage and discontinued projects.
Complete report on H1 2016 pipeline review of Asthma with 217 market data tables and 17 figures, spread across 772 pages is available at http://www.rnrmarketresearch.com/asthma-pipeline-review-h1-2016-market-report.html
The report also reviews key players involved in the therapeutic development for Asthma and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Companies discussed in this Asthma Pipeline Review, H1 2016 report include 4D Pharma Plc, AB Science SA, Abeome Corporation, Accolade Pharmaceuticals, LLC, Acorda Therapeutics, Inc., Adamis Pharmaceuticals Corporation, Advinus Therapeutics Ltd., Afferent Pharmaceuticals, Inc., ALK-Abello A/S, Allergopharma GmbH & Co. KG, Almirall, S.A., Amakem NV, Amgen Inc., AnaptysBio, Inc., Antisense Therapeutics Limited, Aquinox Pharmaceuticals Inc., ARA Healthcare Pvt. Ltd., Ario Pharma Ltd, ASIT biotech s.a., Aslan Pharmaceuticals Pte. Ltd., Astellas Pharma Inc., AstraZeneca Plc, Asubio Pharma Co., Ltd., Aurigene Discovery Technologies Limited, Axikin Pharmaceuticals, Inc., Baxalta Incorporated, Bioncotech Therapeutics S.L., Biotec Pharmacon ASA, Boehringer Ingelheim GmbH, Caladrius Biosciences, Inc., CalciMedica, Inc., Carolus Therapeutics, Inc., Cellceutix Corporation, Cellular Biomedicine Group, Inc., Celon Pharma Sp. z o.o., Chiesi Farmaceutici SpA, Chong Kun Dang Pharmaceutical Corp., Circassia Pharmaceuticals Plc, Cognosci, Inc., CSL Limited, Cumberland Pharmaceuticals, Inc., Cytokinetics, Inc., Daiichi Sankyo Company, Limited, Dynavax Technologies Corporation, F. Hoffmann-La Roche Ltd., Five Prime Therapeutics, Inc., Foresee Pharmaceuticals, LLC, Fountain Biopharma Inc., Genentech, Inc., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., GliaCure Inc., Griffin Discoveries BV, Hanmi Pharmaceuticals, Co. Ltd., Hydra Biosciences, Inc., iCeutica, Inc., iCo Therapeutics Inc., Infinity Pharmaceuticals, Inc., INOXIA Lifesciences GmbH, Invion Limited, Jiangsu Hansoh Pharmaceutical Co., Ltd., Johnson & Johnson, Kineta, Inc., Kissei Pharmaceutical Co., Ltd., Kolltan Pharmaceuticals, Inc., Kyowa Hakko Kirin Co., Ltd., Laboratoires Pierre Fabre SA, Lead Discovery Center GmbH, LegoChem Biosciences, Inc, Ligand Pharmaceuticals, Inc., Lpath, Inc., Marinomed Biotechnologie GmbH, MedImmune, LLC, Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Mycenax Biotech Inc., NAL Pharmaceuticals Ltd., NeoPharm Co., Ltd., Nostrum Pharmaceuticals, LLC, Novartis AG, Omeros Corporation, Ono Pharmaceutical Co., Ltd., OPKO Health, Inc., Orbis Biosciences, Inc., Orion Oyj, Oxagen Limited, Palatin Technologies, Inc., Panacea Biotec Limited, Panmira Pharmaceuticals, LLC., Peptinnovate Limited, PharmaLundensis AB, Pharmaxis Limited, Plexxikon Inc., Polyphor Ltd., Promedior, Inc., Protectimmun GmbH, Pulmagen Therapeutics LLP, Re-Pharm Limited, Regeneron Pharmaceuticals, Inc., Respiratorius AB, ReveraGen BioPharma, Inc., Rhizen Pharmaceuticals S.A., Saje Pharma, LLC, SkyePharma Plc, Spring Bank Pharmaceuticals, Inc., Stallergenes SAS, sterna biologicals Gmbh & Co KG, Sumitomo Dainippon Pharma Co., Ltd., Sun Pharma Advanced Research Company Ltd., Sunovion Pharmaceuticals Inc., Swecure AB, Synovo GmbH, Syntrix Biosystems, Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., The International Biotechnology Center (IBC) Generium, Therabron Therapeutics, Inc., Theraclone Sciences, Inc., Theravance Biopharma, Inc., Tolerys SA, UCB S.A., United BioPharma, Inc., Vectura Group Plc, Verona Pharma Plc, WhanIn Pharmaceutical Co., Ltd., Xencor, Inc., Yungjin Pharm. Co., Ltd., Zambon Company S.p.A. and Ziarco Pharma Ltd.
Order a copy of Asthma - Pipeline Review, H1 2016 market research report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=582455
Another newly published market research report titled Allergic Asthma - Pipeline Review, H1 2016 talks about companies like ALK-Abello A/S, Allergopharma GmbH & Co. KG, Amgen Inc., Aquinox Pharmaceuticals Inc., ASIT biotech s.a., Aslan Pharmaceuticals Pte. Ltd., Axikin Pharmaceuticals, Inc., Baxalta Incorporated, Chiesi Farmaceutici SpA, Circassia Pharmaceuticals Plc, CSL Limited, Fountain Biopharma Inc., GlaxoSmithKline Plc, Hydra Biosciences, Inc., Infinity Pharmaceuticals, Inc., Kineta, Inc., Mabtech Limited, Marinomed Biotechnologie GmbH, Mycenax Biotech Inc., NeoPharm Co., Ltd., Oxagen Limited, Panacea Biotec Limited, Peptinnovate Limited, Pharmaxis Limited, Protectimmun GmbH, Stallergenes SAS, sterna biologicals Gmbh & Co KG, Swecure AB, The International Biotechnology Center (IBC) Generium and Verona Pharma Plc. Allergic Asthma Pipeline market research report of 182 pages is available at http://www.rnrmarketresearch.com/allergic-asthma-pipeline-review-h1-2016-market-report.html
Explore more reports on Asthma Drugs
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Connect with Us:
G+ / Google Plus: https://plus.google.com/104156468549256253075/posts
RSS / Feeds: http://www.rnrmarketresearch.com/feed
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
SOURCE RnR Market Research